URSODEOXYCHOLIC ACID 300mg. IP

A hepatoprotective medication is employed in the management and treatment of cholestatic liver disease. (Achufusi, Safadi, & Mahabadi, 2021) The first choice medication for most cholestatic hepatopathies. (Fernando Bessone, 2016) Counteracts inflammation and bile-acid-induced liver damage. (Fernando Bessone, 2016) Widely recognized as an effective compound in the treatment of chronic hepatitis. (Sakiko Arisawa, 2009) Aids break down cholesterol that has formed into stones in the gallbladder. Protects liver cells from injury caused due to toxic bile acids, and improves liver function. An alternative to cholecystectomy in patients with gallstone disease. (Achufusi T. G., 2021) Shows a significant decrease in the incidence of gallstone disease complications. (Michele Pier Luca Guarino, 2013) Exhibits antioxidant, anti-inflammatory, immunomodulating, and anti-apoptotic effects. (Chao Li, 2020) A beneficial therapeutic agent in various types of liver pathology. (Achufusi, Safadi, & Mahabadi, 2021) Reduces the incidence of biliary pain and acute cholecystitis in patients with symptomatic gallstones. (Michele Pier Luca Guarino S. C., 2013) Delays the development of gastroesophageal varices and progression to cirrhosis. (Angulo, 2002) Improves long-term survival in patients with primary biliary cirrhosis. (Angulo, 2002) Restores gallbladder muscle functions and reduces the biochemical markers of oxidative stress and inflammation. (Michele Pier Luca Guarino P. C., 2007)